clinical trials
Trial for multiple sclerosis drug focused on Hispanic and Black patients
Illustration: Annelise Capossela/Axios
Researchers are conducting what they call a first of its kind clinical trial to study how Hispanic and Bla...
ASCO Spotlight With Hope S. Rugo, MD, FASCO, on Clinical Trial Minority Recruitment, PALOMA-2 Findings
Hope S. Rugo, MD, FASCO, is a professor of medicine and director of Breast Oncology and Clinical Trials Education at the University of California, ...
Clinical Trial Diversity
Clinical trials are an essential component of health care. They help ensure that new medicines or treatments are safe and effective, and they offer...
Making Research Look More Like Its Patients
From the outset of their careers, physicians pledge not to treat “a fever chart, a cancerous growth, but a sick human being.”
They prom...
Why Do Clinical Trials Still Underrepresent Minority Groups?
It’s no secret that, for decades, the participants in clinical trials for new drugs and medical devices haven’t accurately represented ...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
